Quoin Pharmaceuticals, Ltd.

LEO Pharma A/S is not saying for certain that it has closed the door on its ointment formulation of isotretinoin, but said on 21 August the failure of TMB-001 to hit the primary endpoint in a Phase I

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly The Latest Pharma Company To Sign

Neuraxpharm Takes On Established Products From Sanofi Central nervous system specialist Neuraxpharm Arzneimittel GmbH , headquartered in Dusseldorf and Barcelona, announced 12 July that it is strengt

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sino Biopharm Subsidiary Grows Innovati